Interactions between melatonin and estrogen may regulate cerebrovascular function in women: Clinical implications for the effective use of HRT during menopause and aging

Medical Hypotheses

Volumn 64, Issue 4, 2005, Pages 725-735

  Harrod, Christopher G ^a   Bendok, Bernard R ^a   Batjer, H Hunt ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYL 2 ACETAMIDOTETRALINE; ACETYLCHOLINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MELATONIN; MELATONIN 2 RECEPTOR; MELATONIN RECEPTOR; NORADRENALIN; PHENYLEPHRINE; PROGESTERONE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

AGING; ANALYTIC METHOD; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN CIRCULATION; CARDIOVASCULAR RISK; CELL FUNCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM CELL; ESTROGEN BLOOD LEVEL; EXCITOTOXICITY; HEMODYNAMICS; HORMONAL REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; LEUKOCYTE ADHERENCE; MENOPAUSE; MOLECULAR BIOLOGY; NEUROPROTECTION; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SUBARACHNOID HEMORRHAGE; TISSUE STRUCTURE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

EID: 13444283655     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.06.035     Document Type: Article

References (97)

1. D.A. Pelligrino, and E. Galea Estrogen and cerebrovascular physiology and pathophysiology Jpn J Pharmacol 86 2001 137 158
2. J.R. Thompson, D.C. Harwood-Nash, and C.R. Fitz Cerebral aneurysms in children Am J Roentgenol Radium Ther Nucl Med 118 1973 163 175
3. E.M. Housepian, and J.L. Pool A systematic analysis of intracranial aneurysms from the autopsy file of the Presbyterian Hospital 1914 to 1956 J Neuropathol Exp Neurol 17 1958 409 423
4. P.D. Hurn, and I.M. McCrae Estrogen as a neuroprotectant in stroke J Cereb Blood Flow Metab 20 2000 631 652
5. M.E. Mendelsohn, and R.H. Karas The protective effects of estrogen on the cardiovascular system N Engl J Med 340 1999 1801 1811
6. K. Krauchi, C. Cajochen, E. Werth, and A. Wirz-Justice Functional link between distal vasodilation and sleep-onset latency? Am J Physiol Regul Integr Comp Physiol 278 2000 R741 R748
7. I. Wickelgren Brain researchers try to salvage estrogen treatments Science 302 2003 1138 1139
8. V.M. Miller, L.T. Shuster, and S.N. Hayes Controversy of hormone treatment and cardiovascular function: need for strenghthened collaborations between preclinical and clinical scientists Curr Opin Investig Drugs 4 2003 1220 1232
9. T.J.K. Toung, R.J. Traystman, and P.D. Hurn Estrogen-mediated neuroprotection after experimental stroke in male rats Stroke 29 1998 1666 1670
10. Y.Q. Zhang, J. Shi, G. Rajakumar, A.L. Day, and J.W. Simpkins Effects of gender and estradiol treatment in focal brain ischemia Brain Res 784 1998 321 324
11. N.J. Alkayed, I. Harukuni, A.S. Kimes, E.D. London, R.J. Traystman, and P.D. Hurn Gender-linked brain injury in experimental stroke Stroke 29 1998 159 166
12. D.B. Dubal, M.L. Kashon, L.C. Pettigrew, J.M. Ren, S.P. Finkelstein, and S.W. Rau Estradiol protects against ischemic injury J Cereb Blood Flow Metab 18 1998 1253 1258
13. N.J. Alkayed, S.J. Murphy, R.J. Traystman, and P.D. Hurn Neuroprotective effects of female gonadal steroids in reproductively senescent female rats Stroke 31 2000 161 168
14. P.D. Hurn, and L.M. Brass Estrogen and stroke Stroke 34 2003 338
15. S. Wassertheil-Smoller Effect of estrogen plus progestin on stroke in postmenopausal women JAMA 289 2003 2673 2684
16. J.C. Torner Epidemiology of subarachnoid hemorrhage Semin Neurol 4 1984 354 369
17. W.T. Longstreth, L.M. Nelson, T.D. Koepsell, and G. van Belle Subarachnoid hemorrhage and hormonal factors in women Ann Intern Med 121 1994 168 173
18. L.L. Teunissen, G.J.E. Rinkel, A. Alga, and J. van Gijn Risk factors for subarachnoid hemorrhage Stroke 27 1996 544 549
19. A.T. Pederson, O. Lidegaard, S. Kreiner, and B. Ottesen Hormone replacement therapy and risk of non-fatal stroke Lancet 350 1997 1277 1283
20. M.C. Cid, H.W. Schnaper, and H.K. Kleinman Estrogens and the vascular endothelium Ann NY Acad Sci 966 2002 143 157
21. G.G.J.M. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel estrogen receptor expressed in rat prostrate and ovary Proc Natl Acad Sci USA 93 1996 5925 5930
22. S. Mosselman, J. Polman, and R. Dijkema ER-β: identification and characterization of a novel human estrogen receptor FEBS Lett 92 1996 49 53
23. M. Sawada, N.J. Alkayed, S. Goto, B.J. Crain, R.J. Traystman, and A. Shaivitz Estrogen receptor antagonist, ICI182,780, exacerbates ischemic injury in the female mouse J Cereb Blood Flow Metab 20 2000 112 118
24. C.A. Singer, Figueroa-Masot, R.H. Batchelor, and D.M. Dorsa The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons J Neurosci 19 1999 2455 2463
25. D.B. Dubal, H. Zhu, J. Yu, S.W. Rau, P.J. Shughrue, and I. Merchenthaler Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury PNAS 98 2001 1952 1957
26. K. Sampei, S. Goto, N.J. Alkayed, B.J. Crain, K.S. Korach, and R.J. Traystman Stroke in estrogen receptor-α-deficient mice Stroke 31 1999 738 744
27. A.M. McNeill, S.P. Duckles, and D.N. Krause Relaxant effects of 17β-estradiol in the rat tail artery are greater in females than in males Eur J Pharmacol 308 1996 305 309
28. M. Volterrani, G. Rosano, A. Coats, C. Beale, and P. Collins Estrogen acutely increases peripheral blood flow in postmenopausal women Am J Med 99 1995 119 122
29. R. Vargas, M. Delaney, M.Y. Farhat, R. Wolfe, A. Rego, and P.W. Ramwell Effect of estradiol 17β on pressor responses of rat mesenteric bed to norepinephrine, K+, and U-46619 J Cardiovasc Pharmacol 25 1995 200 206
30. M. Ferrer, and G. Osol Estrogen replacement modulates resistance to artery smooth muscle and endothelial α2-adrenoceptor reactivity Endothelium 6 1998 133 141
31. S. Juvela Natural history of unruptured intracranial aneurysms: risks for aneurysm formation, growth, and rupture Acta Neurochir Suppl 82 2002 27 30
32. J.L. Chaso, and W.M. Hindman Berry aneurysms of the circle of willis Neurology 8 1958 41 44
33. H.R. Win, W.S. Almaani, S.L. Berga, J.A. Jane, and A.E. Richardson The long-term outcome in patients with multiple aneurysms. Incidence of late hemorrhage and implications for the treatment of incidental aneurysms J Neurosurg 59 1983 642 651
34. D.O. Weibers, J.P. Whisnant, T.M. Sundt, and W.M. O'Fallon The significance of unruptured intracranial saccular aneurysms J Neurosurg 59 1983 642 651
35. J.R. Ostergaard Risk factors in intracranial saccular aneurysms Acta Neurol Scand 80 1989 81 98
36. W.E. Stehbens Pathology of the cerebral blood vessels 1972 CV Mosby St. Louis p. 351-470
37. W.E. Stehbens Pathology of the cerebral blood vessels 1972 CV Mosby St. Louis p. 60-97
38. P.B. Dobrin, W.H. Baker, and W.C. Gley Elastolytic and collagenolytic studies of arteries Arch Surg 119 1984 405 409
39. T. Stober, S. Sen, T. Anstatt, G. Freier, and K. Schimrigk Direct evidence of hypertension and the possible role of post-menopause estrogen deficiency in the pathogenesis of berry aneurysms J Neurol 232 1985 67 72
40. M.L. Lydrup, and M. Ferno Correlation between estrogen receptor α expression, collagen content and stiffness in human uterine arteries Acta Obstet Gynecol Scand 82 2003 610 615
41. V.M. Miller, and P.M. Vanhoutte Progesterone and modulation of endothelium-dependent 3 responses in canine coronary arteries Am J Physiol Regul Integr Comp Physiol 261 1991 R1022 R1027
42. J. Nilsen, and R.D. Brinton Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonists by medroxyprogesterone acetate Endocrinology 143 2002 205 212
43. Y. Okatani, N. Morioka, and K. Hayashi Changes in nocturnal pineal melatonin synthesis during the premenopausal period: relation to estrogen levels in female rats J Pineal Res 27 1999 65 72
44. M. Karasek, A.J. Kowalski, and K. Zylinska Serum melatonin circadian profile in women suffering from the genital tract cancer Neuroendocrinol Lett 21 2000 109 113
45. Y. Okatani, N. Morioka, and A. Wakatsuki Changes in nocturnal melatonin secretion in perimenopausal women: correlation with endogenous estrogen concentrations J Pineal Res 28 2000 111 118
46. S. Doolen, D.N. Krause, and S.P. Duckles Estradiol modulates vascular response to melatonin in rat caudal artery Am J Physiol Heart Circ Physiol 276 1999 H1281 H1288
47. A.R.A. Abd-Allah, E.S.M. El-Sayed, M.H. Abdel-Wahab, and F.M.A. Hamada Effect of melatonin on estrogen and progesterone receptors in relation to uterine contraction in rats Pharmacol Res 47 2003 349 354
48. Y. Okatani, K. Watanabe, N. Morioka, K. Hayashi, and Y. Sagara Nocturnal changes in pineal melatonin synthesis during puberty: relation to estrogen and progesterone levels in female rats J Pineal Res 22 1997 33 41
49. Y. Okatani, N. Morioka, and K. Hayashi Changes in nocturnal pineal melatonin synthesis during the perimenopausal period: relation to estrogen levels in female rats J Pineal Res 27 1999 65 72
50. M. Karbownik, R.J. Reiter, S. Burkhardt, E. Gitto, D.X. Tan, and A. Lewinski Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention Exp Biol Med 226 2001 707 712
51. S.M. Hill, L.L. Spriggs, N.O. Lawson, and R.E. Harlan Effects of melatonin on estrogen receptor expression in the forebrain of outbred (Lak.LVG) golden hamsters Brain Res 742 1996 107 114
52. T. Keifer, P.T. Ram, L. Yuan, and S.M. Hill Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells Breast Cancer Res Treat 71 2002 37 45
53. A. Cagnacci, R. Soldani, and S.S.C. Yen Melatonin enhances cortisol levels in aged women: reversible by estrogens J Pineal Res 22 1997 81 85
54. J.W. Clemens, M.J. Jarzynka, and P.A. Witt-Enderby Down-regulation of mt1 melatonin receptors in rat ovary following estrogen exposure Life Sci 69 2001 27 35
55. F.J. Hernandez-Diaz, J.J. Sanchez, P. Abreu, I. Lopez-Coviella, L. Tabares, and L. Prieto Estrogen modulates a1/B-adrenoceptor-induced signaling and melatonin production in female rat pinealocytes Neuroendocrinology 73 2001 111 122
56. J.J. Garcia, R.J. Reiter, G.G. Ortiz, C.S. Oh, L. Tang, and B.P. Yu Melatonin enhances tomoxifen's ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation J Membr Biol 162 1998 59 65
57. R.J. Reiter, L. Tang, J.J. Garcia, and A. Munoz-Hoyos Pharmacological actions of melatonin in oxygen radical pathophysiology Life Sci 60 1997 2255 2271
58. S.D. Skaper, M. Floreani, M. Ceccon, L. Facci, and P. Giusti Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin Ann NY Acad Sci 890 1999 107 118
59. R.T.F. Cheung The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion J Pineal Res 34 2003 153 160
60. R.J. Reiter, R.M. Sainz, S. Lopez-Burillo, J.C. Mayo, L.C. Manchester, and D.X. Tan Melatonin ameliorates neurologic damage and neurophysiological deficits in experimental models of stroke Ann NY Acad Sci 993 2003 35 47
61. R.J. Reiter, D.X. Tan, and M. Allegra Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants Neuroendocrinol Lett 23 2002 3 8
62. Y. Okatani, A. Wakatsuki, K. Watanabe, N. Ikenoue, and T. Fukaya Melatonin inhibits vasospastic action of oxidized low-density lipoprotein in human umbilical arteries J Pineal Res 29 2000 74 80
63. N.A. Sattar, A. Bendomir, C. Berry, J. Shepherd, I.A. Greer, and C.J. Packard Lipoprotein subfractions in preeclampsia: pathogenic parallels to atherosclerosis Obstet Gynecol 89 1997 403 408
64. P. Brugger, W. Marktl, and M. Herold Impaired nocturnal secretion of melatonin in coronary heart disease Lancet 345 1995 1408
65. A. Sakotnik, P.M. Liebmann, K. Stoschitzky, P. Lercher, K. Schauenstein, and W. Klein Decreased melatonin synthesis in patients with coronary artery disease Eur Heart J 20 1999 1314 1317
66. P. Fiorina, G. Lattuduada, C. Silvestrini, O. Ponari, and P. Dall'Aglio Disruption of nocturnal melatonin rhythm and immunological involvement in ischemic stroke patients Scand J Immunol 50 1999 228 231
67. D.J. Kennaway, K. Lushington, D. Dawson, L. Lack, C. van den Heuvel, and N. Rogers Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature J Pineal Res 27 1999 210 220
68. C. Ruzcas, and B. Mess Melatonin and aging. A brief survey Neuroendocrinol Lett 21 2000 17 23
69. C.D. Mahle, G.D. Goggins, P.A. Agarwal, E. Ryan, and A.J. Watson Melatonin modulates vascular smooth muscle tone J Biol Rhythm 12 1997 690 696
70. M. Viswanathan, J.T. Laitinen, and J.M. Saavedra Expression of melatonin receptors in arteries involved in thermoregulation Proc Natl Acad Sci USA 87 1990 6200 6203
71. B.K. Evans, R. Mason, and V.G. Wilson Evidence for direct vasoconstrictor activity of melatonin in "pressurized" segments of isolated caudal artery from juvenile rats Naunyn-Schmiedeberg's Arch Pharmacol 346 1992 362 365
72. D.N. Krause, V.E. Barrios, and S.P. Duckles Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery Eur J Pharmacol 276 1995 207 213
73. K. Ting, W. Dunn, D. Davies, D. Sugden, P. Delagrange, and B. Guardiola-Lemaitre Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats Br J Pharmacol 122 1997 1299 1306
74. M. Viswanathan, J.T. Laitinen, and J.M. Saavedra Differential expression of melatonin receptors in spontaneously hypertensive rats Neuroendocrinology 56 1992 864 870
75. G.G. Geary, D.N. Krause, and S.P. Duckles Melatonin directly constricts rat cerebral arteries through modulation of potassium channels Am J Physiol 273 1997 H1530 H1536
76. N. Satake, S. Shibata, and T. Takagi The inhibitory action of melatonin on the contractile response to 5-hyroxytryptamine in various isolated smooth muscles Gen Pharmacol 17 1986 553 558
77. S. Shibata, N. Satake, T. Takagi, and H. Usai Vasorelaxing action of melatonin in rabbit basilar artery Gen Pharmacol 20 1989 677 680
78. L. Weekley Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists J Pineal Res 11 1991 28 34
79. M.M. Anwar, A.R.M.A. Meki, and H.H.A. Rahma Inhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators Comp Biochem Physiol Part C 130 2001 357 367
80. H. Shimokawa Primary endothelial dysfunction Atherosclerosis J Mol Cell Cardiol 31 1999 23 37
81. M.L. Dubocovich, M.I. Masana, S. Iacob, and D.M. Sauri Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor Naunyn-Schmiedeberg's Arch Pharmacol 355 1998 365 375
82. S. Doolen, D.N. Krause, M.L. Dubocovich, and S.P. Duckles Melatonin mediates two distinct responses in vascular smooth muscle Eur J Pharmacol 345 1998 67 69
83. M.I. Masana, S. Doolen, C. Ersahin, W.M. Al-Ghoul, S.P. Duckles, and M.L. Dubocovich MT2 melatonin receptors are present and functional in rat caudal artery J Pharmacol Exp Ther 302 2002 1295 1302
84. J.T. Laitinen, M. Viswanathan, O. Vakkuri, and J.M. Saavedra Differential regulation of the rat melatonin receptors: selective age-associated decline and lack of melatonin-induced changes Endocrinology 130 1992 2139 2144
85. R. Luboshitzky, M. Dharan, D. Goldman, P. Herer, Y. Hiss, and P. Lavie Seasonal variation of gonadotrophins and gonadal steroids receptors in the human pineal gland Brain Res Bull 44 1997 665 670
86. J.D. Johnston, S. Messager, F.J. Ebling, L.M. Williams, P. Barrett, and D.G. Hazlerigg Gonadotrophin-releasing hormone drives melatonin receptor down-regulation in the developing pituitary gland Proc Natl Acad Sci USA 100 2003 2831 2835
87. J.D. Johnston, S. Messager, P. Barrett, and D.G. Hazlerigg Melatonin action in the pituitary: neuroendocrine synchronizer and developmental modulator? J Neuroendocrinol 15 2003 405 408
88. J.M. Soares, M.I. Masana, C. Ersahin, and M.L. Dubocovich Functional melatonin receptors in rat ovaries at various stages of the estrous cycle J Pharmacol Exp Ther 306 2003 694 702
89. P.J. Shughrue, M.V. Lane, and I. Merchenthaler Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system J Comp Neurol 388 1997 507 525
90. P.K. Zahn, T. Lansmann, E. Berger, E.J. Speckmann, and U. Musshoff Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: implications for pain modulation J Pineal Res 35 2003 24 31
91. K. Sano, T. Asano, and T. Tanishima Lipid peroxidation as a cause of cerebral vasospasm Neurol Res 2 1980 253 272
92. T. Kamezaki, K. Yanaka, S. Nagase, K. Fujita, N. Kato, and T. Nose Increased levels of lipid peroxides as predictive of symptomatic vasospasm and poor outcome after aneurysmal subarachnoid hemorrhage J Neurosurg 97 2002 1302 1305
93. C. Ruzcas, and B. Mess Melatonin and aging. A brief survey Neuroendocrinol Lett 21 2000 17 23
94. G. Bellipanni, P. Bianchi, W. Pierpaoli, D. Bulian, and E. Ilyia Effects of melatonin in perimenopausal and menopausal women randomized and placebo controlled study Exp Gerontol 36 2001 297 310
95. R.J. Reiter Melatonin and human reproduction Ann Med 30 1998 103 108
96. I.S. Shergill, N.K. Shergill, M. Arya, and H.R.H. Patel Tissue microarrays: a current medical research tool Curr Med Res Opin 20 2004 707 712
97. T.P. Padera, B.R. Stoll, P.T.C. So, and R.K. Jain Conventional and high-speed intravital multiphoton laser scanning microscopy of microvasculature, lymphatics, and leukocyte-endothelial interactions Mol Imaging 1 2002 9 15